Literature DB >> 4912633

An appraisal of chloroquine.

A H Mackenzie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4912633     DOI： 10.1002/art.1780130310

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

Review 1.  Novel paradigms for drug discovery: computational multitarget screening.

Authors:  Ekachai Jenwitheesuk; Jeremy A Horst; Kasey L Rivas; Wesley C Van Voorhis; Ram Samudrala
Journal:  Trends Pharmacol Sci       Date:  2008-01-10       Impact factor: 14.819

2.  Neurotoxic effects of chloroquine in vitro.

Authors:  A Bruinink; G Zimmermann; F Riesen
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

3.  Effect of chloroquine on the PHA-induced lymphocyte transformation.

Authors:  T Ruzicka; H Loosen; D Strassburger; G Goerz
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

4.  [Postnatal development of the rat retina under DNS-inhibitor (chloroquinediphosphate) mediation (author's transl)].

Authors:  R Ferrier; W Lierse
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1975-11-25

5.  Chloroquine: its effect on leucocyte auto- and heterophagocytosis.

Authors:  C J Jones; M I Jayson
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis.

Authors:  J S Dixon; M E Pickup; H A Bird; M R Lee; V Wright; W W Downie
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

Review 7.  Remission-inducing drugs in rheumatoid arthritis.

Authors:  T P Anastassiades
Journal:  Can Med Assoc J       Date:  1980-02-23       Impact factor: 8.262

Review 8.  A bibliometric review of drug repurposing.

Authors:  Nancy C Baker; Sean Ekins; Antony J Williams; Alexander Tropsha
Journal:  Drug Discov Today       Date:  2018-01-09       Impact factor: 7.851

Review 9.  Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.

Authors:  K D Rainsford; Ann L Parke; Matthew Clifford-Rashotte; W F Kean
Journal:  Inflammopharmacology       Date:  2015-08-06       Impact factor: 5.093
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.